Divergent regulation of 1,25-dihydroxyvitamin D3 on human bone marrow osteoclastogenesis and myelopoiesis

Journal of Cellular Biochemistry

Volumn 72, Issue 3, 1999, Pages 387-395

  Qi, Dan Yi ^a,c   Perkins, Sherrie L ^a   Kling, Stephen J ^a   Russell, R Graham G ^b  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

^c MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Differentiation; Hematopoietic progenitor; IL 1; Osteoclast like cell; Proliferation; TNF

Indexed keywords

CALCITRIOL;

ARTICLE; CANCER CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; COLONY FORMING CELL; CONTROLLED STUDY; HUMAN; HUMAN CELL; MYELOPOIESIS; OSTEOCLAST; PRIORITY JOURNAL; VITAMIN METABOLISM;

BONE MARROW; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL DIVISION; DIHYDROXYCHOLECALCIFEROLS; DOSE-RESPONSE RELATIONSHIP, DRUG; ERYTHROPOIETIN; HEMATOPOIETIC STEM CELLS; HUMANS; INTERLEUKIN-1; LEUKOPOIESIS; OSTEOCLASTS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0344959419     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4644(19990301)72:3<387::AID-JCB8>3.0.CO;2-7     Document Type: Article

References (43)

1. Abboud SL, Gerson SL, Berger NA. 1987. The effect of tumor necrosis factor on normal human hematopoietic progenitors. Cancer 60:2965-2970.
2. Abu-Amer Y, Bar-Shavit Z. 1994. Regulation of TNF-α release from bone marrow-derived macrophages by vitamin D. J Cell Biochem 55:435-444.
3. Abu-Amer Y, Ross FP, Edwards J, Teitelbaum SL. 1997. Lipopolysaccharide-stimulated osteoclastogenesis is mediated by tumor necrosis factor via its P55 receptor. J Clin Invest 100:1557-1565.
4. Bartelmez SH, Bradley TR, Bertoncello I, Mochizuki DY, Tushinski RJ, Stanley ER, Hapel AJ, Young IG, Kriegler AB, Hodgson GS. 1989. Interleukin 1 plus interleukin 3 plus colony-stimulating factor 1 are essential for clonal proliferation of primitive myeloid bone marrow cells. Exp Hematol 17:240-245.
5. Bellido T, Girasole G, Passen G, Yu XP, Mocharla H, Jilka RL, Notides A, Manolagas SC. 1993. Demonstration of estrogen and vitamin D receptors in bone marrow-derived stromal cells: Up-regulation of the estrogen receptor by 1,25-dihydroxyvitamin-D3. Endocrinology 133:553-562.
6. Bertolini DR, Nedwin GE, Bringman TS, Smith DD, Mundy GR. 1986. Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factors. Nature 319:516-518.
7. 3. Immunology 72:61-64.
8. Davies J, Warwick J, Totty N, Philp R, Helfrich M, Horton M. 1989. The osteoclast functional antigen, implicated in the regulation of bone resorption, is biochemically related to the vitronectin receptor. J Cell Biol 109:1817-1826.
9. Dinarello CA. 1996. Biologic basis for interleukin-1 in disease. Blood 87:2095-2147.
10. 3 inhibits myelopoiesis but not B-lymphopoiesis in long-term bone marrow cultures. Exp Hematol 17:436-442.
11. Fan X, Biskobing DM, Bain S, Rubin J. 1996. Ketoconazole and phorbol myristate acetate regulate osteoclast precursor fusion in primary murine marrow culture. J Bone Miner Res 11:1274-1280.
12. Fujikawa y, Quinn JM, Sabokbar A, MaGee JO, Athanasou NA. 1996. The human osteoclast precursor circulates in the monocyte fraction. Endocrinology 137:4058-4060.
13. Gabrilove JL, Weite K, Harris P, Platzer E, Lu L, Levi E, Mertelsmann R, Moore MA. 1986. Pluripoietin α: A second human hematopoietic colony-stimulating factor produced by the human bladder carcinoma cell line 5637. Proc Natl Acad Sci USA 83:2478-2482.
14. 3 treatment on production of tumor necrosis factor-α by peripheral blood mononuclear cells and on serum concentrations of soluble tumor necrosis factor receptors in hemodialysis patients. Nephron 66:262-266.
15. Haynesworth SE, Baber MA, Caplan AI. 1996. Cytokine expression by human marrow-derived mesenchymal progenitor cells in vitro: Effects of dexamethasone and IL-1 alpha. J Cell Physiol 166:585-592.
16. Herrmann F, Bambach T, Bonifer R, Lindemann A, Riedel D, Oster W, Mertelsmann R. 1988. The suppressive effects of recombinant human tumor necrosis factor-α on normal and malignant myelopoiesis: Synergism with interferon-γ. Int J Cell Cloning 6:241-261.
17. Higashimoto Y, Ohata M, Iwamoto Y, Fujimoto H, Uetani K, Suruda T, Nakamura Y, Nakai S, Funasako M. 1995. Stimulatory effect of 1 alpha,25-dihydroxyvitamin D3 on mouse alveolar macrophage tumor necrosis factor-alpha production in vitro: Involvement of protein kinase C and Ca2+/calmodulin-dependent kinase. Respiration 62:89-94.
18. Horton MA, Lewis D, McNulty K, Pringle JAS, Chambers TJ. 1985. Monoclonal antibodies to osteoclastomas (giant cell bone tumors): Definition of osteoclast-specific cellular antigens. Cancer Res 45:5663-5669.
19. Jacobsen N, Broxmeyer HE, Grossbard E, Moore MAS. 1979. Colony-forming units in diffusion chambers (CFU-d) and colony-forming units in agar culture (CFU-c) obtained from normal human bone marrow: A possible parent-progeny relationship. Cell Tissue Kinet 12:213-226.
20. Kimble RB, Srivastava S, Ross FP, Matayoshi A, Pacifici R. 1996. Estrogen deficiency increases the ability of stromal cells to support murine osteoclastogenesis via an interleukin-1 and tumor necrosis factor-mediated stimulation of macrophage colony-stimulating factor production. J Biol Chem 271:28890-28897.
21. Kimble RB, Bain S, Pacifici R. 1997. The functional block of TNF but not of IL-6 prevents bone loss in ovariectomized mice. J Bone Miner Res 12:935-941.
22. 3 receptor RNA: Expression in hematopoietic cells. Blood 77:1238-1247.
23. 3H-tetracycline excretion from prelabeled mice. J Bone Miner Res 3:621-627.
24. Kurihara N, Chenu C, Miller M, Civin C, Roodman GD. 1990. Identification of committed mononuclear precursors for osteoclast-like cells formed in long term human marrow cultures. Endocrinology 126:2733-2741.
25. Kurihara N, Civin C, Roodman GD. 1991. Osteotropic factor responsiveness of highly purified populations of early and late precursors for human multinucleated cells expressing the osteoclast phenotype. J Bone Miner Res 6:257-261.
26. MacDonald BR, Takahashi N, McManus LM, Holahan J, Mundy GR, Roodman GD. 1987. Formation of multinucleated cells that respond to osteotropic hormones in long term human bone marrow cultures. Endocrinology 120:2326-2333.
27. McNiece IK, Kriegler AB, Quesenberry PJ. 1989. Studies on the myeloid synergistic factor from 5637: Comparison with interleukin-1α. Blood 73:919-923.
28. 3 induces differentiation of human myeloid leukemia cells. Biochem Biophys Res Commun 102:937-943.
29. Murphy M, Perussia B, Trinchieri G. 1988. Effects of recombinant tumor necrosis factor, lymphotoxin, and immune interferon on proliferation and differentiation of enriched hematopoietic precursor cells. Exp Hematol 16:131-138.
30. 3 modulates colony-stimulating factor-1 receptor binding by murine bone marrow macrophage precursors. Endocrinology 128:303-311.
31. Pfeilschifter J, Chenu C, Bird A, Mundy GR, Roodman GD. 1989. Interleukin-1 and tumor necrosis factor stimulate the formation of human osteoclast-like cells in vitro. J Bone Miner Res 4:113-118.
32. 3. Blood 80:2811-2816.
33. 3 receptors in human leukocytes. Science 221:1181-1183.
34. Roux S, Quinn J, Pichaud F, Orcel P, Chastre E, Jullienne A, De Vernejoul MC. 1996. Human cord blood monocytes undergo terminal osteoclast differentiation in vitro in the presence of culture medium conditioned by giant cell tumor of bone. J Cell Physiol 168:489-498.
35. Sarma U, Flanagan AM. 1996. Macrophage colony-stimulating factor induces substantial osteoclast generation and bone resorption in human bone marrow cultures. Blood 88:2531-2540.
36. Schiller C, Gruber R, Redlich K, Ho GM, Katzgraber F, Willheim M, Pietschmann P, Peterlik M. 1997. 17Beta-estradiol antagonizes effects of 1alpha,25-dihydroxyvitamin D3 on interleukin-6 production and osteoclast-like cell formation in mouse bone marrow primary cultures. Endocrinology 138:4567-4571.
37. Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang MS, Luthy R, Nguyen HQ, Wooden S, Bennett L, Boone T, Shimamoto G, DeRose M, Elliott R, Colombero A, Tan HL, Trail G, Sullivan J, Davy E, Bucay N, Renshaw-Gegg L, Hughes TM, Hill D, Pattison W, Campbell P, Boyle WJ. 1997. Osteoprotegerin: A novel secreted protein involved in the regulation of bone density. Cell 89:309-319.
38. Smith C, Gasparetto C, Collins N, Gillio A, Muench MO, O'Reilly RJ, Moore MAS. 1991. Purification and partial characterization of a human hematopoietic precursor population. Blood 77:2122-2128.
39. Suda T, Jimi E, Nakamura I, Takahashi N. 1997. Role of 1 alpha,25-dihydroxyvitamin D3 in osteoclast differentiation and function. Methods Enzymol 282:223-235.
40. Testa NG. 1985. Clonal assays for haemopoietic and lymphoid cells in vitro. In: Potten CS, Hendry JH, editors. Cell clones: Manual of mammalian cell techniques. Edinburgh: Churchill Livingstone. p 27-43.
41. Yamane T, Kunisada T, Yamazaki H, Era T, Nakano T, Hayashi SI. 1997. Development of osteoclasts from embryonic stem cells through a pathway that is c-fms but not c-kit dependent. Blood 90:3516-3523.
42. Zhou YQ, Stanley ER, Clark SC, Hatzfeld JA, Levesque JP, Federici C, Watt SM, Hatzfeld A. 1988. Interleukin-3 and interleukin-1α allow earlier bone marrow progenitors to respond to human colony-stimulating factor 1. Blood 72:1870-1874.
43. Zsebo KM, Wypych J, Yuschenkoff VN, Lu H, Hunt P, Dukes PP, Langley KE. 1988. Effects of hematopoietin-1 and interleukin 1 activities on early hematopoietic cells of the bone marrow. Blood 71:962-968.